|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,040.00 USD | +0.33% |
|
-1.72% | -3.23% |
| 14/02 | Soros Fund Management cuts share stake in Alphabet, raises share stake in Apple, Uber | RE |
| 13/02 | US could take action including fines against Hims after brief Wegovy copy launch | RE |
| Capitalization | 93TCr 78TCr 71TCr 68TCr 1,26500Cr 84,15000Cr 1,31500Cr 8,30500Cr 3,29700Cr 40,63700Cr 3,48400Cr 3,41300Cr 1,42,02900Cr | P/E ratio 2026 * |
31.1x | P/E ratio 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise value | 95TCr 80TCr 73TCr 69TCr 1,28800Cr 85,63100Cr 1,33800Cr 8,45100Cr 3,35500Cr 41,35300Cr 3,54600Cr 3,47300Cr 1,44,53000Cr | EV / Sales 2026 * |
11.8x | EV / Sales 2027 * | 9.84x |
| Free-Float |
99.81% | Yield 2026 * |
0.63% | Yield 2027 * | 0.71% |
Last Transcript: Eli Lilly and Company
| 1 day | +0.33% | ||
| 1 week | -1.72% | ||
| Current month | +0.27% | ||
| 1 month | -3.10% | ||
| 3 months | +1.44% | ||
| 6 months | +51.95% | ||
| Current year | -3.23% |
| 1 week | 1,012 |  | 1,106.94 |
| 1 month | 993.58 | | 1,114 |
| Current year | 993.58 | | 1,133.95 |
| 1 year | 623.78 | | 1,133.95 |
| 3 years | 309.2 | | 1,133.95 |
| 5 years | 178.58 | | 1,133.95 |
| 10 years | 64.18 | | 1,133.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.48% | 6.49% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.33% | -1.72% | +23.18% | +199.23% | 93TCr | |
| -0.45% | +1.44% | +55.91% | +50.24% | 59TCr | |
| +1.76% | +3.61% | +20.03% | +51.71% | 41TCr | |
| +0.08% | +1.01% | +20.89% | +28.94% | 37TCr | |
| +1.42% | +7.19% | +26.36% | +32.36% | 32TCr | |
| +1.08% | +4.32% | +27.98% | +55.61% | 31TCr | |
| +1.82% | -0.43% | +46.26% | +11.65% | 30TCr | |
| +1.32% | +5.11% | -45.12% | -37.51% | 22TCr | |
| +1.52% | -3.94% | +26.80% | +53.17% | 20TCr | |
| +2.09% | +1.63% | +48.90% | +80.88% | 19TCr | |
| Average | +1.10% | +1.96% | +25.12% | +52.63% | 38.41TCr | |
| Weighted average by Cap. | +0.81% | +1.58% | +27.66% | +76.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.02TCr 6.76TCr 6.16TCr 5.88TCr 11TCr 7,26200Cr 11TCr 72TCr 28TCr 3,50700Cr 30TCr 29TCr 12,25600Cr | 9.38TCr 7.9TCr 7.21TCr 6.88TCr 13TCr 8,49200Cr 13TCr 84TCr 33TCr 4,10100Cr 35TCr 34TCr 14,33200Cr |
| Net income | 3.04TCr 2.56TCr 2.34TCr 2.23TCr 4.14TCr 2,75500Cr 4.3TCr 27TCr 11TCr 1,33000Cr 11TCr 11TCr 4,64900Cr | 3.61TCr 3.04TCr 2.77TCr 2.65TCr 4.92TCr 3,27000Cr 5.11TCr 32TCr 13TCr 1,57900Cr 14TCr 13TCr 5,52000Cr |
| Net Debt | 1.64TCr 1.38TCr 1.26TCr 1.2TCr 2.23TCr 1,48100Cr 2.31TCr 15TCr 5.8TCr 72TCr 6.13TCr 6.01TCr 2,50000Cr | -617.45Cr -520.26Cr -474.53Cr -453.04Cr -840.96Cr -56TCr -873.76Cr -5.52TCr -2.19TCr -27TCr -2.32TCr -2.27TCr -94TCr |
Employees
50,000
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 1,040.00 $ | +0.17% | 26,98,728 |
| 12/26/12 | 1,038.27 $ | +2.27% | 35,92,172 |
| 11/26/11 | 1,015.21 $ | -0.96% | 25,99,875 |
| 10/26/10 | 1,025.00 $ | -1.88% | 35,39,394 |
| 09/26/09 | 1,044.67 $ | -1.28% | 34,23,770 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
1,040.00USD
Average target price
1,201.63USD
Spread / Average Target
+15.54%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition